eLife shifts to publishing ‘reviewed preprints’, ending accept/reject decisions
eLife hopes inclusion of open peer review reports and standardised assessments will help improve transparency and accessibility of research.
Are your AI-generated data reproducible?
AI-based science comes under scrutiny: read about the growing crisis in machine learning.
Are research data FAIR enough?
Find out why, despite implementation of mandates, current research data may not be FAIR.
Raise the Papermill Alarm! A new tool for identifying potential fake articles
Read about the new weapon in the fight against bogus scientific research articles.
Clear and present data: identifying barriers to clinical trial transparency
What’s standing in the way of researchers adopting good practices on clinical trial data sharing and transparency?
Transparent peer review: are authors willing to publish referee reports?
Read about the results of Nature’s transparent peer review pilot and how it could benefit the research community.
How accurate are conflict-of-interest disclosures in high-impact journals?
Find out how authors’ self-disclosures compare with payment data reported by the medical industry.
Data sharing and reporting still suboptimal in vaccine trials
A recent analysis of randomised controlled vaccine trials suggests there are still improvements to be made.
WHO mandates health-related data sharing
Learn all about the new WHO data sharing policy and their practical guidance on data sharing plans.
Language-generating AI in science: transformational or deformational?
Read about the potential impacts of large language models, and what needs to happen to ensure they benefit, rather than hinder, scientific fields.
Exposing the gender gap in peer reviewing
An analysis of 47 BMJ journals found that under one-third of peer reviewers were women.
How common is data sharing for COVID-19 preprints?
An analysis of early COVID-19 preprints identified low uptake of data sharing statements and making data accessible.
Are we still missing the mark with randomised controlled trial abstracts?
Adherence to the Consolidated Standards of Reporting Trials for Abstracts continues to be inadequate, nearly 15 years after their release.
Addressing race and ethnicity in medical literature
Learn about the current failings in race and ethnicity reporting in regulatory documents and medical literature and how they can be overcome.
The reality of data sharing behaviour: do researchers share their data as promised?
A recent study revealed that many researchers fail to comply with their data sharing statement.
CHEERS 2022 statement: reporting guidance for health economic evaluations gets a makeover
Read about the new 28-item checklist developed to aid decision-making in health economic evaluations.